Autoimunidade familial e poliautoimunidade em 60 pacientes portadores de esclerose sistêmica da região Centro‐Oeste do Brasil
Authors:
- Alex Magno Coelho HorimotoAHAlex Magno Coelho Horimoto
- Izaias Pereira da CostaICIzaias Pereira da Costa
Open Access
- 1 July 2016
- journal article
- Published by Springer Nature in Revista Brasileira de Reumatologia
- Vol. 56 (4) , 314-322
Abstract
Systemic sclerosis (SSc) is a connective tissue disease of unknown etiology, characterized by a triad of vascular injury, autoimmunity and tissue fibrosis. It is known that a positive family history is the greatest risk factor already identified for the development of SSc in a given individual. Preliminary observation of a high prevalence of poliautoimmunity and of familial autoimmunity in SSc patients support the idea that different autoimmune phenotypes may share common susceptibility variants. To describe the frequency of familial autoimmunity and poliautoimmunity in 60 SSc patients in the Midwest region of Brazil, as well as to report the main autoimmune diseases observed in this association of comorbidities. A cross-sectional study with recruitment of 60 consecutive patients selected at the Rheumatology Department, University Hospital, Medicine School, Federal University of Mato Grosso do Sul (FMUFMS), as well as interviews of their relatives during the period from February 2013 to March 2014. A frequency of 43.3% of poliautoimmunity and of 51.7% of familial autoimmunity in SSc patients was found. Patients with presence of poliautoimmunity and familial autoimmunity presented primarily the diffuse form of SSc, but this indicator did not reach statistical significance. The autoimmune diseases most frequently observed in poliautoimmunity patients were: Hashimoto's thyroiditis (53.8%), Sjögren's syndrome (38.5%), and inflammatory myopathy (11.5%). The main autoimmune diseases observed in SSc patients' relatives were: Hashimoto's thyroiditis (32.3%), rheumatoid arthritis (22.6%), and SLE (22.6%). The presence of more than one autoimmune disease in SSc patients did not correlate with disease severity or activity. From the high prevalence of coexisting autoimmune diseases found in SSc patients, we stress the importance of the concept of shared autoimmunity, in order to promote a continued vigilance and promptly diagnose other possible autoimmune disease in patients, or in their kin.Keywords
This publication has 37 references indexed in Scilit:
- The epigenetics of autoimmunityCellular & Molecular Immunology, 2011
- Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosisJournal of Autoimmunity, 2010
- Geoepidemiology of autoimmune rheumatic diseasesNature Reviews Rheumatology, 2010
- Systemic sclerosis: a prototypic multisystem fibrotic disorderJournal of Clinical Investigation, 2007
- Assessing disability and quality of life in systemic sclerosis: Construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36‐Item Short Form Health SurveyArthritis Care & Research, 2007
- Genetic factors in systemic sclerosisArthritis Research & Therapy, 2007
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Is there a Common Genetic Basis for Autoimmune Diseases?Journal of Immunology Research, 2006
- Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.Annals of the Rheumatic Diseases, 1993
- Major histocompatibility complex class II genes and systemic sclerosis.Annals of the Rheumatic Diseases, 1991